Press Releases on November 5, 2020 - EIN Presswire - Press Release Distribution Service

Published on November 5, 2020 - 21:05 GMT

CymaBay Reports Third Quarter 2020 Financial Results and Provides Corporate Update

CymaBay announces trial design for RESPONSE, a global phase 3 registration study for seladelpar in primary biliary cholangitis (PBC) Results from the ENHANCE phase 3 study evaluating seladelpar for PBC to be featured in an oral, late-breaking presentation …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on November 5, 2020 - 21:05 GMT

The Joint Corp. Reports Third Quarter 2020 Financial Results

- Grows Revenue 21%, Compared to Q3 2019 – - Reports Record Net Income of $1.6 Million, Up 160% Compared to Q3 2019 – - Posts Record Adjusted EBITDA of $2.6 Million, Up 84% Compared to Q3 2019 - - Increases Total Clinic Count to 560, Opening 22 Clinics in …

Distribution channels:

Published on November 5, 2020 - 21:05 GMT

Potbelly Corporation Reports Results for Third Fiscal Quarter 2020

Business continued to improve through third quarter as SSS have increased for six consecutive months through the end of October, helping Company reach profitability at the shop level Leadership outlines new strategic focus on “Traffic Driven Profitability” …

Distribution channels: Business & Economy, Travel & Tourism Industry ...

Published on November 5, 2020 - 21:05 GMT

Chembio Diagnostics Reports Third Quarter 2020 Financial Results

HAUPPAUGE, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter ended September 30, 2020. Recent …

Distribution channels: Business & Economy ...

Published on November 5, 2020 - 21:05 GMT

Aravive Reports Third Quarter 2020 Financial Results and Provides Corporate Updates

Company expects to initiate pivotal trial of AVB-500 in Platinum Resistant Ovarian Cancer during fourth quarter 2020/first quarter 2021, based on Phase 1b results On-track to initiate Phase 1b/2 trial of AVB-500 in Clear Cell Renal Cell Carcinoma during …

Distribution channels:

Published on November 5, 2020 - 21:05 GMT

ManTech Announces Financial Results for Third Quarter of 2020

Revenue: $636 million, up 10% from the third quarter of 2019 EBITDA Margin: 9.0% Diluted EPS: $0.73, up 6% from the third quarter of 2019 Adjusted Diluted EPS: $0.83, up 6% from the third quarter of 2019 Bookings of $1.3 billion resulting in a book-to-bill …

Distribution channels:

Published on November 5, 2020 - 21:05 GMT

A-Mark Precious Metals Sets Fiscal First Quarter 2021 Earnings Call for Tuesday, November 10 at 4:30 p.m. ET

EL SEGUNDO, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- A-Mark Precious Metals, Inc. (NASDAQ: AMRK), a leading full-service provider of products and services to the global precious metals market, will hold a conference call on Tuesday, November 10 at 4:30 p. …

Distribution channels: Culture, Society & Lifestyle, Mining Industry ...

Published on November 5, 2020 - 21:05 GMT

Entasis Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Business Update

WALTHAM, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced today its third quarter 2020 …

Distribution channels:

Published on November 5, 2020 - 21:05 GMT

Bellicum Reports Third Quarter 2020 Financial Results and Provides Operational Update

Strategic focus on clinical GoCAR-T® programs with plans to initiate Phase 1/2 enrollment of BPX-601 in mCRPC and BPX-603 in HER2+ solid tumors by end of year Completed offering of shares of common stock plus warrants that raised gross proceeds of …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 5, 2020 - 21:05 GMT

Lam Research Corporation Announces $5 Billion Share Repurchase Authorization and Declares Quarterly Dividend

FREMONT, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Lam Research Corporation (Nasdaq: LRCX) today announced that its Board of Directors approved a $5 billion share repurchase authorization and a quarterly dividend of $1.30 per share of common stock. The …

Distribution channels: Automotive Industry, Banking, Finance & Investment Industry ...

Published on November 5, 2020 - 21:05 GMT

Mitek Surpasses $100 Million in Annual Revenue and Sets Financial Records

SAN DIEGO, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Mitek (NASDAQ: MITK, www.miteksystems.com) today reported record financial results for both its fiscal 2020 fourth quarter and full year ended September 30, 2020. Total fourth quarter revenue increased 22% and …

Distribution channels: Business & Economy, Technology ...

Published on November 5, 2020 - 21:05 GMT

Sarepta Therapeutics Announces Third Quarter 2020 Financial Results and Recent Corporate Developments

– Net product sales of $121.4 million, a 23% increase over same quarter of prior year – CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported …

Distribution channels:

Published on November 5, 2020 - 21:05 GMT

Benefitfocus Announces Third Quarter 2020 Financial Results

Exceeds high end of revenue and adjusted EBITDA guidance Outlines priorities to unlock shareholder value CHARLESTON, S.C., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Benefitfocus, Inc. (NASDAQ: BNFT), an industry-leading benefits technology platform that …

Distribution channels:

Published on November 5, 2020 - 21:05 GMT

GBT Reports Recent Business Progress and Third Quarter 2020 Financial Results

Achieved Oxbryta® (voxelotor) net revenues of $36.9 million with more than 1,000 new patient prescriptions in the third quarter and net revenues of $82.5 million through first nine months of 2020 New Oxbryta data and new research on GBT’s pipeline to be …

Distribution channels:

Published on November 5, 2020 - 21:05 GMT

ADMA Biologics Reports Third Quarter 2020 Financial Results and Business Highlights

Generated Total Revenues of $28.3 Million for the First Nine Months of 2020, Reflecting a 63% Increase Over the Same Prior Year Period Successfully Opened Newest ADMA BioCenters Plasma Collection Facility; On Track to Achieve Stated Goal of Opening Five to …

Distribution channels: Business & Economy, Technology ...

Published on November 5, 2020 - 21:05 GMT

CarGurus Announces Third Quarter 2020 Results

Third Quarter Highlights: Total revenue of $147.5 million, a decrease of (2%) year-over-year GAAP operating income of $43.6 million; non-GAAP operating income of $55.1 million GAAP net income of $32.6 million; non-GAAP net income of $41.9 million Adjusted …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on November 5, 2020 - 21:05 GMT

ATEC Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights

U.S. Revenue Grows 43% Eighth Consecutive Quarter of Double-Digit Revenue Growth CARLSBAD, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions …

Distribution channels:

Published on November 5, 2020 - 21:05 GMT

CorMedix Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update

BERKELEY HEIGHTS, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 5, 2020 - 21:05 GMT

Arcutis Announces Third Quarter 2020 Financial Results and Provides Business Update

Pivotal Phase 3 data in plaque psoriasis anticipated in first quarter of 2021 Pivotal Phase 3 trials in atopic dermatitis anticipated to begin in late 2020 or early 2021 Recent positive Phase 2 data in seborrheic dermatitis supports pipeline advancement in …

Distribution channels: Business & Economy, Technology ...

Published on November 5, 2020 - 21:05 GMT

BigCommerce Announces Third Quarter Financial Results

Third Quarter Total Revenue of $39.7 Million, an Increase of 41% Versus Prior Year Total ARR of $167.0 Million, an Increase of 38% Versus Prior Year AUSTIN, Texas, Nov. 05, 2020 (GLOBE NEWSWIRE) -- BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), …

Distribution channels: